Motohara K, Matsukane I, Endo F, Kiyota Y, Matsuda I
Department of Internal Medicine, Kamiamakusa General Hospital, Kumamoto, Japan.
Pediatrics. 1989 Jul;84(1):90-3.
Vitamin K status was evaluated by measuring blood acarboxyprothrombin (PIVKA-II) levels on the fifth day of life. The incidence of PIVKA-II-positive infants was higher in breast-fed babies than in those given supplementary (mixed) feeding. The median of total amount of milk intake during the first 3 days was significantly lower in PIVKA-II-positive infants than in PIVKA-II-negative infants among infants given both types of feedings. In addition, there was a significant negative correlation between a positive PIVKA-II proportion and the amount of milk intake in the breast-fed babies. The minimum dose of vitamin K2 necessary to prevent a positive PIVKA-II reading was 15 micrograms among babies with a normal absorption potential.
通过在出生后第五天测量血液中脱羧基凝血酶原(PIVKA-II)水平来评估维生素K状态。母乳喂养婴儿中PIVKA-II阳性婴儿的发生率高于接受补充(混合)喂养的婴儿。在接受两种喂养方式的婴儿中,PIVKA-II阳性婴儿出生后头3天的总奶量中位数显著低于PIVKA-II阴性婴儿。此外,母乳喂养婴儿中PIVKA-II阳性比例与奶量摄入之间存在显著负相关。在吸收潜力正常的婴儿中,预防PIVKA-II读数呈阳性所需的维生素K2最小剂量为15微克。